113 related articles for article (PubMed ID: 19156864)
21. Practical aspects of therapeutic intervention in rheumatoid arthritis.
Thompson A
J Rheumatol Suppl; 2009 Jun; 82():39-41. PubMed ID: 19509329
[TBL] [Abstract][Full Text] [Related]
22. Retention rates of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
Agarwal S; Zaman T; Handa R
Singapore Med J; 2009 Jul; 50(7):686-92. PubMed ID: 19644623
[TBL] [Abstract][Full Text] [Related]
23. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
[TBL] [Abstract][Full Text] [Related]
24. [Cardiovascular risk in patients with rheumatoid arthritis].
Nikitina NM; Rebrov AP
Ter Arkh; 2009; 81(6):29-34. PubMed ID: 19663189
[TBL] [Abstract][Full Text] [Related]
25. Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients.
Flint-Wagner HG; Lisse J; Lohman TG; Going SB; Guido T; Cussler E; Gates D; Yocum DE
J Clin Rheumatol; 2009 Jun; 15(4):165-71. PubMed ID: 19279507
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?
McLean-Tooke A; Aldridge C; Waugh S; Spickett GP; Kay L
Rheumatology (Oxford); 2009 Aug; 48(8):867-71. PubMed ID: 19447771
[TBL] [Abstract][Full Text] [Related]
27. Differences in longitudinal disease and treatment characteristics of patients with rheumatoid arthritis replying and not replying to a postal questionnaire. Experience from a biologics register in southern Sweden.
Söderlin MK; Jacobsson LT; Petersson IF; Englund M; Saxne T; Geborek P
J Rheumatol; 2009 Jun; 36(6):1166-9. PubMed ID: 19411397
[TBL] [Abstract][Full Text] [Related]
28. Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study.
Verschueren P; Esselens G; Westhovens R
Scand J Rheumatol; 2009; 38(3):166-72. PubMed ID: 19169906
[TBL] [Abstract][Full Text] [Related]
29. Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis.
Odai T; Matsunawa M; Takahashi R; Wakabayashi K; Isozaki T; Yajima N; Miwa Y; Kasama T
J Rheumatol; 2009 Jun; 36(6):1158-65. PubMed ID: 19369458
[TBL] [Abstract][Full Text] [Related]
30. Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab.
Schmid L; Müller M; Treumann T; Arnold W; Möller B; Aeberli D; Villiger PM
Arthritis Rheum; 2009 Jun; 60(6):1632-4. PubMed ID: 19479865
[TBL] [Abstract][Full Text] [Related]
31. Endovascular treatment of septic thrombophlebitis: a case report of a rare complication and review of the literature.
Schifferdecker B; Merchán JA; Ahmar C; Worthington M; Griben A; Schainfeld RM; Soukas PA
Vasc Med; 2009 Feb; 14(1):47-50. PubMed ID: 19144779
[TBL] [Abstract][Full Text] [Related]
32. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.
Lu LJ; Bao CD; Dai M; Teng JL; Fan W; Du F; Yang NP; Zhao YH; Chen ZW; Xu JH; He PG; Wu HX; Tao Y; Zhang MJ; Han XH; Li XF; Gu JR; Li JH; Yu H
Arthritis Rheum; 2009 Jul; 61(7):979-87. PubMed ID: 19565542
[TBL] [Abstract][Full Text] [Related]
33. [Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil].
Sergiets NA; Erov NK
Ter Arkh; 2009; 81(6):34-7. PubMed ID: 19663190
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of high-throughput leukocytapheresis for rheumatoid arthritis with a reduced response to infliximab.
Sakai Y; Sakai S; Otsuka T; Ohno D; Murasawa T; Munakata K; Mizuno K
Ther Apher Dial; 2009 Jun; 13(3):179-85. PubMed ID: 19527463
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular risk in rheumatoid arthritis.
Nurmohamed MT
Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life in rheumatoid arthritis patients in South India.
Mathew AJ; Antony J; Eremenco S; Paul BV; Jayakumar B; Philip J
Singapore Med J; 2009 Aug; 50(8):800-3. PubMed ID: 19710980
[TBL] [Abstract][Full Text] [Related]
38. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
39. Medico-economic evaluation of infliximab in rheumatoid arthritis--prospective French study of a cohort of 635 patients monitored for two years.
Sany J; Cohen JD; Combescure C; Bozonnat MC; Roch-Bras F; Lafon G; Daurès JP
Rheumatology (Oxford); 2009 Oct; 48(10):1236-41. PubMed ID: 19620209
[TBL] [Abstract][Full Text] [Related]
40. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.
Nyhäll-Wåhlin BM; Petersson IF; Nilsson JA; Jacobsson LT; Turesson C;
Rheumatology (Oxford); 2009 Apr; 48(4):416-20. PubMed ID: 19213849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
